secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jasper Therapeutics, Inc. (JSPR)
CIK:        0001788028
Form:       8-K
Filed at:   2021-09-29T23:59:59+00:00
Accession:  0001213900-21-050592
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.01, 9.01, 5.02, 3.02, 4.01, 5.01, 5.06, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Amplitude Healthcare completes business combination with Jasper Therapeutics; begins trading as JSPR
--------------------------------------------------------------------------------

- Redemption of 9,262,099 AMHC shares for $92.7M; PIPE of $100M from 10M shares at $10.00 each.
- Old Jasper equity valued at $275M; post-closing shares: 36.5M voting, 1.3M non-voting, 2.7M options.
- Sponsor deposited 1,050,000 earnout shares subject to price thresholds of $11.50, $15, $18 VWAP.
- New company renamed Jasper Therapeutics, Inc.; tickers JSPR (common) and JSPRW (warrants) on Nasdaq.
- Amended registration rights agreement with 180-day lock-up; indemnification agreements with directors/officers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1788028/000121390021050592/0001213900-21-050592-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1788028/000121390021050592/ea147929-8k_jasper.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-050592

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer